HIV prevention drug hailed as breakthrough, but who gets access?

we should not have to spend more than a year trying to find a way to buy a WHO-recommended medicine." She emphasized that people in humanitarian crises and conflict zones cannot wait, as daily oral PrEP pills are difficult to adhere to under such conditions compared to a six-month injection. "People living through conflict [and] humanitarian crises cannot be the last in line for medical innovation," she said.